D. S. Davies - Concepedia

Author

D. S. Davies

London Postgraduate Medical and Dental Education

Also Known As

D S Davies, D. S. DAVIES, D. S. Davies, D.S. Davies, Donald S. Davies

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

London Postgraduate Medical and Dental Education Hammersmith Hospital National Cancer Institute

About

D. S. Davies is an author at London Postgraduate Medical and Dental Education specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	782
2	Natural Sciences	8	8	439
3	Health Sciences	4	4	124
4	Public Health	2	2	31
5	Allergy	1	1	25

D. S. Davies

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Pharmacokinetics and concentration‐effect relationships of intravenous and oral clonidine D. S. Davies, L. M. H. Wing, John L. Reid, Clinical Pharmacology & Therapeutics	1977	257
The specificity of inhibition of debrisoquine 4-hydroxylase activity by quinidine and quinine in the rat is the inverse of that in man Shinichi Kobayashi, Stephen Murray, David G. Watson, Biochemical Pharmacology Medicinal ChemistryBiochemistryAntiparasitic AgentMedicineNatural Sciences	1989	126
Contribution of CYP1A1 and CYP1A2 to the activation of heterocyclic amines in monkeys and human Robert J. Edwards, Bernard P. Murray, Stephen A. Murray, Carcinogenesis	1994	125
Extra-nuclear location of histones in activated human peripheral blood lymphocytes and cultured T-cells Keith Watson, Robert J. Edwards, Sunil Shaunak, Biochemical Pharmacology Extra-nuclear LocationChromatinChromatin StructureCell DivisionChromatin Remodeling	1995	83
The cardiac effects of terfenadine after inhibition of its metabolism by grapefruit juice C. Clifford, Delyth A Adams, Stephen A. Murray, European Journal of Clinical Pharmacology Cardiac EffectsMedicinePhysiologyCardiovascular PharmacologyPharmacotherapy	1997	69
Differential induction of antipyrine metabolism by rifampicin EL Toverud, Alan R. Boobis, Martin J. Brodie, European Journal of Clinical Pharmacology Medicinal ChemistryPharmacological StudyBiochemistryMedicineNatural Sciences	1981	69
Dose‐dependent enzyme induction A Breckenridge, Michael Orme, L. Davies, Clinical Pharmacology & Therapeutics Molecular PharmacologyTherapeutic Drug MonitoringPharmacokinetic ModelingPharmacodynamicsBiochemistry	1973	67
Substrate specificity of the form of cytochrome P-450 catalyzing the 4-hydroxylation of debrisoquine in man. Alan R. Boobis, Sandra Murray, GC Kahn, Molecular Pharmacology	1983	66
Determination of human hepatic cytochrome P4501A2 activity in vitro use of tacrine as an isoenzyme-specific probe. Vanessa Spaldin, Stephen F. Madden, Delyth A Adams, Drug Metabolism and Disposition	1995	54
Sex and strain differences in hepatic debrisoquine 4-hydroxylase activity of the rat. GC Kahn, Marc Rubenfield, D. S. Davies, Drug Metabolism and Disposition	1985	54

Page 1